VBI Vaccines and Brii Biosciences Expand Hepatitis B Partnership To Address Both Prevention and Treatment in License and Collaboration Agreements for up to $437 Million Plus Royalties
Brii Biosciences has acquired worldwide exclusive license to VBI-2601 and an exclusive license for PreHevbri®…